Paul North

Welcome to August’s analysis of the MedBud traffic data. The most interesting month we have had yet, and a clear sign that the data we analyse provides a real time …

The UK government’s decision to ban xylazine, while aimed at addressing public health concerns, has been accompanied by deeply troubling rhetoric, labelling the substance as a “zombie drug.” This kind …

As the use of prescription cannabis becomes increasingly common in the UK, landlords and housing associations are facing a new legal challenge: how to accommodate tenants who use medical cannabis. …

Former President Donald Trump’s recent support for the legalisation of adult-use cannabis in Florida, via Amendment 3, marks a significant shift in both his political strategy and the Republican Party’s …

Labour’s recent proposal to ban disposable vapes, citing concerns over youth access and environmental impact, is a significant misstep. While these issues warrant attention, an outright ban ignores the crucial …

Overdose Awareness Day, observed annually on the 31st of August, is a critical event for raising awareness about the growing issue of drug overdoses. This day not only honours those …

When the UK’s medical cannabis market was launched in 2018, I remember the palpable sense of optimism. We were confident that this would lead to a rapid and transformative impact …

Labour’s proposal to ban smoking in pub gardens isn’t just an overreach of government power; it’s a direct threat to personal freedom, common sense, and the pub trade—a vital part …

Ukraine’s recent legalisation of medical cannabis represents a significant step forward in the nation’s evolving drug policy. However, this progress is marred by a critical omission: the exclusion of post-traumatic …

A recent report from the U.S. Centers for Disease Control and Prevention (CDC) has provided compelling evidence that legalising cannabis does not lead to increased use among teenagers. In fact, …